ToxGenSolutions
About:
(Epi-)genetics for preclinical diagnostics and preventative therapeutics for high-impact chronic neurodegenerative and rare pathologies
Website: https://toxgen.solutions
Top Investors: European Union, ToxGenSolutions, Alzheimer's Drug Discovery Foundation, Eurostars, NWO
Description:
(Epi-)genetic approaches addressing molecular initiation events and key events of adverse outcome pathways driving pathologies like neurodegeneration, cancer and immune-dysfunction.
Total Funding Amount:
$1.83M
Headquarters Location:
Maastricht, Limburg, The Netherlands
Founded Date:
2015-05-22
Contact Email:
stan.goertz(AT)toxgen.solutions
Founders:
Erwin Roggen
Number of Employees:
1-10
Last Funding Date:
2023-01-30
IPO Status:
Private
Industries:
© 2025 bioDAO.ai